COMBINATION THERAPIES FOR MODULATION OF HISTONE METHYL MODIFYING ENZYMES

摘要

Provided herein are pharmaceutical compositions comprising an EZH2 inhibitor and a type I interferon, processes for preparing such pharmaceutical compositions, and uses thereof in modulating the activity of histone methyl modifying enzymes.